Results 131 to 140 of about 27,020 (235)

Desenvolvimento da farmacoepidemiologia no Brasil: I Seminário Brasileiro de Farmacoepidemiologia The development of pharmacoepidemiology in Brazil: I Brazilian Seminar on Pharmacoepidemiology

Cadernos de Saúde Pública, 1999
Helena Lutéscia Luna Coêlho, Paulo Sérgio Dourado Arrais   +1 more
doaj   +1 more source

Antiseizure Medication Dispensing Before and After Initiation of Antidementia Medicines: A Population‐Based Matched Cohort Study

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 11, November 2026.
ABSTRACT Purpose Seizures and behavioural and psychiatric features may prompt antiseizure medication (ASM) use in dementia. We examined whether increased ASM dispensing precedes or follows initiation of antidementia treatment to inform hypotheses about when these indications emerge.
Osvaldo P. Almeida, Christopher Etherton‐Beer, Frank M. Sanfilippo, David B. Preen, Amy Page   +4 more
wiley   +1 more source

Pharmacoepidemiology and public health day: learning beyond the classroom [PDF]

Pharmacoepidemiology and Public Health Day was successfully conducted on 19 December 2025 as part of the learning activities for second-year pharmacy students.
Shapri, Nik Aisyah Najwa Nik Mustaffa, Zakaria, Yuslina   +1 more
core  

Use of selective serotonin reuptake inhibitors and risk of myeloid malignancy: A nationwide Danish case–control study

British Journal of Haematology, Volume 209, Issue 5, Page 2127-2135, November 2026.
Summary Preclinical and clinical studies suggest that selective serotonin reuptake inhibitors (SSRIs) can stimulate haematopoiesis by promoting proliferation and mobilization of haematopoietic stem and progenitor cells, but whether SSRI use influences myeloid malignancy risk remains unclear.
Katrine Mose, Anton Pottegård, Mette Reilev, Christen Lykkegaard Andersen, Blánaid Hicks, Mathilde Egelund Christensen   +5 more
wiley   +1 more source

Tirzepatide Persistence and Associated Changes in Clinical Outcomes in US Adults With Obesity or Overweight: A 6‐Month Claims Database Analysis

Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 9966-9979, November 2026.
ABSTRACT Aims Tirzepatide is a once‐weekly glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) approved in the US for the treatment of Type 2 diabetes (T2D), weight loss and obstructive sleep apnoea. This study aimed to assess the utilisation and effectiveness of tirzepatide among individuals in a large ...
Theresa Hunter Gibble, Malvika Venkataraman, Donna Mojdami, Carlos Vallarino, Grace Stockbower, Michael Grabner, Mythili Ananth, Karishma Desai   +7 more
wiley   +1 more source

Increasing Trends in Hospitalisation With Diabetic Ketoacidosis at Type 1 Diabetes Diagnosis Among Children and Youth in the United States and England, 2002–2020

Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 10615-10624, November 2026.
ABSTRACT Background There is a paucity of population‐level data evaluating trends in the proportion of children and youth hospitalised with diabetic ketoacidosis (DKA) at the time of Type 1 diabetes (T1D) diagnosis. Methods National Medicaid (US publicly insured claims), MarketScan (US commercially insured claims) and Clinical Practice Research ...
Chintan V. Dave, Kristen Lloyd, Abner Nyandege, Jason Roy, Raquel López‐Díez, Sally Radovick, Brian L. Strom   +6 more
wiley   +1 more source

Sex Differences in Prescribing Patterns of Anticholinergics and β3‐Adrenoceptor Agonists for Overactive Bladder: A Nationwide Study in Japan, FY2017–FY2024

LUTS: Lower Urinary Tract Symptoms, Volume 18, Issue 6, November 2026.
ABSTRACT Objectives Drug treatment for overactive bladder (OAB) is changing, with an increasing share of β3‐adrenoceptor agonists relative to anticholinergics, but it is not known how far this change has progressed in older people, who are most vulnerable to the risks of anticholinergics.
Toshikazu Koike, Takashi Kawahara, Akihito Hashizume, Masanobu Yamazaki, Daiji Takamoto, Hiroki Ito, Teppei Takeshima, Hiroji Uemura, Kazuhide Makiyama, Jun‐Ichi Teranishi   +9 more
wiley   +1 more source

Evidence of West Nile Virus Infections in Wild Boars (Sus scrofa) in the Netherlands, 2018–2021

Zoonoses and Public Health, Volume 73, Issue 7, Page 670-679, November 2026.
ABSTRACT Introduction Orthoflaviviruses are emerging in Europe and have potential significant impact on animal and public health. Usutu virus (USUV) and West Nile virus (WNV) have been first detected in the Netherlands in 2016 and 2020, respectively. Wild boars (Sus scrofa) have been suggested as an interesting population to detect the circulation of ...
Kiki Streng, Eduardo de Freitas Costa, Sophie van Oort, Renate Hakze‐van der Honing, Gebbiena Bron, Carl Andreas Grøntvedt, Wim H. M. van der Poel, Nathanaël Hozé, Michel Counotte   +8 more
wiley   +1 more source

International Society for Pharmacoepidemiology in Action: Advancing Public Health Through Evidence-Based Advocacy. [PDF]

Pharmacoepidemiol Drug Saf
Sarri G, Diaz-Decaro J, Burcu M, Soriano Gabarró M, Gini R, Bahri P, Ritchey ME.   +6 more
europepmc   +1 more source

Involving Patients in Pharmacoepidemiology Studies Conducted on Healthcare Administrative Database: Results of a Feasibility Study in France. [PDF]

Health Expect
Rigoureau J, Verroul M, Vieillard V, Termoz A, Panse L, Havet A, Viprey M, Haesebaert J.   +7 more
europepmc   +1 more source